| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
1998-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f665082e21026c187679a5021bb3bf0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba8e93b510c2ef6a636ceefebfe8961 |
| publicationDate |
1998-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9830585-A2 |
| titleOfInvention |
Use of pea3 in tumor suppression |
| abstract |
The present invention relates generally to the fields of cancer therapy and gene therapy. More particularly, it demonstrates that PEA3 is a tumor suppressor and may be used to treat various forms of cancer, and especially neu-mediated cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0004153-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6248351-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7641905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7951375-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7927597-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7628989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7736654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6582725-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0004153-A3 |
| priorityDate |
1997-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |